Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil
- 1 October 2001
- journal article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 20 (10), 1035-1043
- https://doi.org/10.1016/s1053-2498(01)00305-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Scientific principles for mycophenolic acid therapeutic drug monitoringTransplantation Proceedings, 1998
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- Mycophenolate mofetil in cardiac transplantationCurrent Opinion in Cardiology, 1998
- Pharmacokinetics of Mycophenolate Mofetil in Heart Transplant RecipientsAdvances in experimental medicine and biology, 1998
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- Anti-T-cell-antibody prophylaxis in children: Success with a novel combination strategy of mycophenolate mofetil and antithymocyte serumTransplantation Proceedings, 1997
- Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantationTransplantation Proceedings, 1997
- Mycophenolate MofetilDrugs, 1996
- RS-61443—A PHASE I CLINICAL TRIAL AND PILOT RESCUE STUDY 1Transplantation, 1992
- Lymphocyte‐Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide DepletionScandinavian Journal of Immunology, 1991